Want to join the conversation?
$NSC 2Q15 Q&A: Group of Wolfe Research asked about stock based comp rough guidance for 3Q & 4Q15. Marta replied that stock based comp did have a very large decrease in 2Q15. Going forward in to 3Q and 4Q15 we think we still will have favorable comparisons in that line item, but they will be to the degree they were in 2Q15.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?